These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8866571)

  • 1. Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.
    Greenbaum CJ; Kahn SE; Palmer JP
    Diabetes; 1996 Nov; 45(11):1631-4. PubMed ID: 8866571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
    Lampeter EF; Klinghammer A; Scherbaum WA; Heinze E; Haastert B; Giani G; Kolb H
    Diabetes; 1998 Jun; 47(6):980-4. PubMed ID: 9604880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide treatment in subjects at high risk of developing IDDM improves insulin secretion.
    Manna R; Migliore A; Martin LS; Ferrara E; Ponte E; Marietti G; Scuderi F; Cristiano G; Ghirlanda G; Gambassi G
    Br J Clin Pract; 1992; 46(3):177-9. PubMed ID: 1286017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The Nicotinamide Trialists.
    Pozzilli P; Browne PD; Kolb H
    Diabetes Care; 1996 Dec; 19(12):1357-63. PubMed ID: 8941464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
    Cabrera-Rode E; Molina G; Arranz C; Vera M; González P; Suárez R; Prieto M; Padrón S; León R; Tillan J; García I; Tiberti C; Rodríguez OM; Gutiérrez A; Fernández T; Govea A; Hernández J; Chiong D; Domínguez E; Di Mario U; Díaz-Díaz O; Díaz-Horta O
    Autoimmunity; 2006 Jun; 39(4):333-40. PubMed ID: 16891222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide.
    Elliott RB; Chase HP
    Diabetologia; 1991 May; 34(5):362-5. PubMed ID: 1830860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
    Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High proinsulin levels in late PRE-IDDM stage.
    Rodríguez-Villar C; Conget I; Casamitjana R; Vidal J; Manzanares JM; Gomis R
    Diabetes Res Clin Pract; 1997 Aug; 37(2):145-8. PubMed ID: 9279485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1-beta, tumour necrosis factor-alpha, islet-cell antibody, and insulin secretion in children with thalassemia major on long-term blood transfusion.
    el Nawawy A; Soliman AT; el Azzouni O; Abbassy AA; Massoud MN; Marzouk S; Ibrahim F; Helal L
    J Trop Pediatr; 1996 Dec; 42(6):362-4. PubMed ID: 9009565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide and insulin secretion in normal subjects.
    Bingley PJ; Caldas G; Bonfanti R; Gale EA
    Diabetologia; 1993 Jul; 36(7):675-7. PubMed ID: 8359586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decrease of early insulin secretion, risk factor of insulin-dependent diabetes. Prospective study in families with diabetic children].
    Robert JJ; Boitard C; Mogenet A; Chevenne D; Roger M; Deschamps I
    Arch Fr Pediatr; 1991 Jan; 48(1):11-7. PubMed ID: 2018414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
    Pozzilli P; Visalli N; Signore A; Baroni MG; Buzzetti R; Cavallo MG; Boccuni ML; Fava D; Gragnoli C; Andreani D
    Diabetologia; 1995 Jul; 38(7):848-52. PubMed ID: 7556988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics.
    Olmos PR; Hodgson MI; Maiz A; Manrique M; De Valdés MD; Foncea R; Acosta AM; Emmerich MV; Velasco S; Muñiz OP; Oyarzún CA; Claro JC; Bastías MJ; Toro LA
    Diabetes Res Clin Pract; 2006 Mar; 71(3):320-33. PubMed ID: 16233932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.
    McCulloch DK; Klaff LJ; Kahn SE; Schoenfeld SL; Greenbaum CJ; Mauseth RS; Benson EA; Nepom GT; Shewey L; Palmer JP
    Diabetes; 1990 May; 39(5):549-56. PubMed ID: 2185106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).
    European Nicotinamide Diabetes Intervention Trial Group
    Diabetologia; 2003 Mar; 46(3):339-46. PubMed ID: 12687331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
    Bingley PJ
    Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group].
    Reimers JI; Andersen HU; Pociot F
    Ugeskr Laeger; 1994 Jan; 156(4):461-5. PubMed ID: 8140661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
    Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.